These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11158183)

  • 21. Routine ovary removal during hysterectomy ill-advised for most women.
    Harv Womens Health Watch; 2009 Jul; 16(11):7. PubMed ID: 19777675
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prophylactic surgery in common hereditary cancer syndromes].
    Noguès C; Mouret-Fourme E
    Bull Acad Natl Med; 2012 Oct; 196(7):1237-45. PubMed ID: 23815011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic laparoscopy in gynecological cancer, prophylactic oophorectomy: feasibility study on 22 cases].
    Le Brun JF; Dravet F; Campion L; Classe JM
    J Gynecol Obstet Biol Reprod (Paris); 2014 Mar; 43(3):229-34. PubMed ID: 24095301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic oophorectomy comes of age.
    Rubin SC
    Gynecol Oncol; 2002 Jun; 85(3):395-6. PubMed ID: 12051864
    [No Abstract]   [Full Text] [Related]  

  • 25. Occult ovarian cancer at the time of risk-reducing salpingo-oophorectomy.
    Powell CB
    Gynecol Oncol; 2006 Jan; 100(1):1-2. PubMed ID: 16368438
    [No Abstract]   [Full Text] [Related]  

  • 26. Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
    Pérez-López FR; Ceausu I; Depypere H; Kehoe S; Lambrinoudaki I; Mueck A; Senturk LM; Simoncini T; Stevenson JC; Stute P; Rees M
    Maturitas; 2017 Jun; 100():86-91. PubMed ID: 28389043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new strategy for prophylactic surgery in BRCA women: Combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap.
    Hunsinger V; Marchac AC; Derder M; Hivelin M; Lecuru F; Bats AS; Lantieri L
    Ann Chir Plast Esthet; 2016 Jun; 61(3):177-82. PubMed ID: 26946931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation carriers.
    Foulkes WD
    J Natl Cancer Inst; 2003 Sep; 95(17):1344; author reply 1344. PubMed ID: 12953090
    [No Abstract]   [Full Text] [Related]  

  • 29. [Residual ovary after hysterectomy. Is castration at peri-menopause necessary to prevent ovarian cancer?].
    Kazadi Buanga J; Rovira Montane J; Laparte Escorza M; Lopez Garcia G
    Rev Fr Gynecol Obstet; 1994 Jan; 89(1):15-20. PubMed ID: 8134758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.
    Paley PJ; Swisher EM; Garcia RL; Agoff SN; Greer BE; Peters KL; Goff BA
    Gynecol Oncol; 2001 Feb; 80(2):176-80. PubMed ID: 11161856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers.
    Kenkhuis MJ; de Bock GH; Elferink PO; Arts HJ; Oosterwijk JC; Jansen L; Mourits MJ
    Maturitas; 2010 Jul; 66(3):310-4. PubMed ID: 20409655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic oophorectomy in Northern Ireland.
    Fogarty P
    Ulster Med J; 1991 Oct; 60(2):172-5. PubMed ID: 1785152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current surgical practice of prophylactic and opportunistic salpingectomy in France].
    Chene G; de Rochambeau B; Le Bail-Carval K; Beaufils E; Chabert P; Mellier G; Lamblin G
    Gynecol Obstet Fertil; 2016; 44(7-8):377-84. PubMed ID: 27363615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.
    Meeuwissen PA; Seynaeve C; Brekelmans CT; Meijers-Heijboer HJ; Klijn JG; Burger CW
    Gynecol Oncol; 2005 May; 97(2):476-82. PubMed ID: 15863147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy.
    ACOG
    Obstet Gynecol; 2008 Jan; 111(1):231-41. PubMed ID: 18165419
    [No Abstract]   [Full Text] [Related]  

  • 36. Prophylactic surgery: oophorectomy or adnexectomy?
    Delaloge S; Morice P; Chompret A; Lhommé C
    J Clin Oncol; 2000 Oct; 18(19):3454-5. PubMed ID: 11013293
    [No Abstract]   [Full Text] [Related]  

  • 37. Dogma, skepsis, and the analytic method: the role of prophylactic oophorectomy at the time of hysterectomy.
    Olive DL
    Obstet Gynecol; 2005 Aug; 106(2):214-5. PubMed ID: 16055566
    [No Abstract]   [Full Text] [Related]  

  • 38. Worsening of menopausal flushes after prophylactic oophorectomy.
    Poulose T; Ashelby L; Fox R
    J Obstet Gynaecol; 2006 Jul; 26(5):481-2. PubMed ID: 16846894
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.
    Villella JA; Parmar M; Donohue K; Fahey C; Piver MS; Rodabaugh K
    Gynecol Oncol; 2006 Sep; 102(3):475-9. PubMed ID: 16473397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutation carriers in Japan: a preliminary report.
    Shigehiro M; Kita M; Takeuchi S; Ashihara Y; Arai M; Okamura H
    Jpn J Clin Oncol; 2016 Mar; 46(3):254-9. PubMed ID: 26685323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.